Health Economic Evaluation of Lung Cancer Screening Using a Diagnostic Blood Test: The Early Detection of Cancer of the Lung Scotland (ECLS).

Jose Antonio Robles-ZuritaNicola McMeekinFrank M Sullivan Frances S MairAndrew Briggs

Published in: Current oncology (Toronto, Ont.) (2024)

The ECLS intervention is the most cost-effective screening alternative, with the highest probability of being cost-effective, when compared to no screening or LDCT screening. This result may change with modifications of the parameters, suggesting that the three alternatives considered in the main analysis are potentially cost-effective.

Keyphrases

healthcare
randomized controlled trial
public health
mental health
health information